Protection of focal ischemic infarction by rilmenidine in the animal: Evidence that interactions with central imidazoline receptors may be neuroprotective
Open Access
- 22 December 1994
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 74 (13) , A25-A30
- https://doi.org/10.1016/0002-9149(94)90038-8
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Expression of non-adrenergic imidazoline sites in chromaffin cells and mitochondrial membranes of bovine adrenal medullaBiochemical Pharmacology, 1993
- Reduction in Focal Cerebral Ischemia by Agents Acting at Imidazole ReceptorsJournal of Cerebral Blood Flow & Metabolism, 1992
- Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 areaEuropean Journal of Pharmacology, 1991
- Protection against Ischemia-Induced Neuronal Damage by the α2-Adrenoceptor Antagonist Idazoxan: Influence of Time of Administration and Possible Mechanisms of ActionJournal of Cerebral Blood Flow & Metabolism, 1990
- Further Characterization of the Guinea Pig Cerebral Cortex Idazoxan Receptor: Solubilization, Distinction from the Imidazole Site, and Demonstration of Cirazoline as an Idazoxan Receptor‐Selective DrugJournal of Neurochemistry, 1990
- The imidazoline-preferring receptorLife Sciences, 1989
- Are there multiple imidazoline binding sites?Trends in Pharmacological Sciences, 1989
- Postischemic Administration of Idazoxan, an α-2 Adrenergic Receptor Antagonist, Decreases Neuronal Damage in the Rat BrainJournal of Cerebral Blood Flow & Metabolism, 1989
- The imidazoline preferring receptor: binding studies in bovine, rat and human brainstemEuropean Journal of Pharmacology, 1989
- Clonidine binds to imidazole binding sites as well as α2-adrenoceptors in the ventrolateral medullaEuropean Journal of Pharmacology, 1987